Sachs Associates would like to say we enjoyed hosting a virtual conference and thank those who participated in our Sachs Spring Life Sciences Week, which incorporated the 2nd Annual European HealthTech CEO Forum (EHTF) and the 14th Annual European Life Sciences CEO Forum (ELSF). A special thank you goes to the excellent line up of sponsors, chairpersons, panelists and presenters who made such a broad and interesting programme possible.
The virtual conference is proving successful in supporting our community with 372 people from 33 countries registered and over 10,000 messages sent, nearly 1300 meetings completed during the Sachs Spring Life Sciences Week
We look forward to seeing you in our future events !
SPOTLIGHT PRESENTERS INCLUDED:
PRESENTING COMPANIES INCLUDED:
CONFIRMED KEYNOTE SPEAKERS INCLUDED:
Introductory Speech by Jeffrey Cohen, Managing Director, Equity Research, Ladenburg Thalmann & Co. Inc.
“Blitzscaling” atoms vs bytes: Key learnings from pandemic response by Mark Stevenson, Executive Vice President & Chief Operating Officer, Thermo Fisher Scientific
"Vaccine Rollout Put in Israel and Global Lessons" by Prof. Ran Balicer, MD, PhD, MPh, Chief Innovation Officer, Clalit Health Services
Fireside Chat with Sean Marett, Chief Business Officer & Chief Commercial Officer, BioNTech SE, moderated by Mike Ward, Global Head of Thought Leadership, Life Sciences and Healthcare, Clarivate
SPEAKERS & CHAIRS INCLUDED:
Alex Zhavoronkov, Founder & CEO, Insilico Medicine, Inc.
Alexandra Vallon-Eberhard, Sr. Director Global BD, Roche Diagnostics
Amir Jafri, Founder & CEO, Immunicom, Inc.
André Heeg, Managing Director & Partner, BCG Digital Ventures
Andreas Neubert, Chief Scientific Officer, IDT Biologika GmbH
Arild Kristensen, CEO, Norwegian Smart Care Cluster (NSCC)
Axel Nemetz, Independent
Beat Merz, Managing Director, New Harbor Venture Partners, LLC
Christoph Pedain, Head of Point of Care Diagnostics, Siemens Healthineers AG
Daniel O’Mahony, Partner, Seroba Life Sciences
Daniel Vitt, President & CEO, Immunic Therapeutics
David Cole, Leader EMEA, IBM Watson Health
David Gordon, Head of Investments, Longliv Ventures
Diana Saraceni, Co-Founder & General Partner, Panakès Partners SGR SpA
Dominik Pförringer, Academic Director of Venture Lab Healthcare, TU Munich
Elena Bonfiglioli, Managing Director Health and Life Sciences, EMEA, Microsoft Corporation
Eyal Zimlichman, Deputy Director General, CMO and CIO, Sheba Medical Center
Florian Schödel, Owner, Philimmune, LLC
Gilead Raday, COO, RedHill Biopharma Ltd.
Guy Spigelman, EMEA Lead, Healthcare & Life Sciences Startups, Amazon Web Services
3B Future Health Ventures Sarl (Helsinn Investment Fund) 3E Bioventures Additio Investment Group Advent Life Sciences Aisling Capital LLC Aqua Partners LLC ARCH Venture Partners Asabys Partners Asklepios Advisors ATEM Capital LLC Atlas Advisors LLC BCG Digital Ventures Bci Bergmann zur Hausen & Cie. GmbH BERNINA BioInvest Ltd. Bioscience Managers Biotech Alliances International, Inc. Biotechnology Business Institute Bootstrap Europe Boston Scientific Breslin AG BRESLIN AG & LSFA Brothers & Partners Europe Bryan, Garnier & Co. GmbH BTIG, LLC Capricorn Partners NV Cederberg GmbH Claris Ventures Clavis Capital Ltd. Crosswave Management, Inc. Curam Capital Management LLP DeBere Capital Partners Digital Networks Plc. S.r.l. Dorset Capital LLC Draper Esprit